Form 13-F position report

ANAVEX LIFE SCIENCES CORP

Reported by MORGAN STANLEY

AVXL CUSIP 032797300 Manager CIK 0000895421

Reported 414,151 shares, up 219,188 (112.4%) from the prior quarter.

Reported value 65.7%; share count 112.4% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 414,151 Quarter-end amount reported
Reported value $836,583 Fair value at quarter end
Consecutive quarters held 44 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 6195000
2022-03-31 9179000
2022-06-30 8455000
2022-09-30 2252000
2022-12-31 3551053
2023-03-31 2240940
2023-06-30 2214730
2023-09-30 1783195
2023-12-31 4210014
2024-03-31 1733810
2024-06-30 1847686
2024-09-30 4081394
2024-12-31 9710668
2025-03-31 7419370
2025-06-30 5782855
2025-09-30 4985325
2025-12-31 1690488
2026-03-31 1098283
2026-06-30 504955
2026-09-30 836583

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ANAVEX LIFE SCIENCES CORP held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 414,151 +219,188 (112.4%) < 0.01% $836,583 2026-11-13
Q2 2026 Reduced 194,963 -162,784 (-45.5%) < 0.01% $504,955 2026-08-13
Q1 2026 Reduced 357,747 -117,109 (-24.7%) < 0.01% $1,098,283 2026-05-15
Q4 2025 Reduced 474,856 -85,292 (-15.2%) < 0.01% $1,690,488 2026-02-13
Q3 2025 Reduced 560,148 -67,059 (-10.7%) < 0.01% $4,985,325 2025-11-14
Q2 2025 Reduced 627,207 -237,521 (-27.5%) < 0.01% $5,782,855 2025-08-15
Q1 2025 Reduced 864,728 -39,431 (-4.4%) < 0.01% $7,419,370 2025-05-15
Q4 2024 Added 904,159 +185,604 (25.8%) < 0.01% $9,710,668 2025-02-14
Q3 2024 Added 718,555 +280,715 (64.1%) < 0.01% $4,081,394 2024-11-14
Q2 2024 Added 437,840 +97,210 (28.5%) < 0.01% $1,847,686 2024-08-14
Q1 2024 Reduced 340,630 -111,573 (-24.7%) < 0.01% $1,733,810 2024-05-15
Q4 2023 Added 452,203 +179,960 (66.1%) < 0.01% $4,210,014 2024-02-13
Q3 2023 Reduced 272,243 -171 (-0.1%) < 0.01% $1,783,195 2023-11-15
Q2 2023 Added 272,414 +10,928 (4.2%) < 0.01% $2,214,730 2023-08-14
Q1 2023 Reduced 261,486 -121,997 (-31.8%) < 0.01% $2,240,940 2023-05-15
Q4 2022 Added 383,483 +165,312 (75.8%) < 0.01% $3,551,053 2023-02-14
Q3 2022 Reduced 218,171 -626,644 (-74.2%) < 0.01% $2,252,000 2022-11-14
Q2 2022 Added 844,815 +99,208 (13.3%) < 0.01% $8,455,000 2022-08-15
Q1 2022 Added 745,607 +388,392 (108.7%) < 0.01% $9,179,000 2022-05-13
Q4 2021 Added 357,215 +107,828 (43.2%) < 0.01% $6,195,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

190 managers reported ANAVEX LIFE SCIENCES CORP for Q3 2026.

Managers reporting ANAVEX LIFE SCIENCES CORP in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 8,144,147 +88,519 < 0.01% $16,451,176 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 4,094,908 +40,319 < 0.01% $8,271,714 3 qtrs
GMT CAPITAL CORP New 2,704,364 +2,704,364 0.26% $5,462,815 1 qtr
FEDERATED HERMES INC Added 2,585,094 +1,513,285 < 0.01% $5,221,890 6 qtrs
TWO SIGMA INVESTMENTS LP Reduced 2,336,420 -710,118 < 0.01% $4,719,568 19 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 2,275,241 -132,232 < 0.01% $4,597,169 44 qtrs
STATE STREET CORPORATION Added 1,958,409 +35,639 < 0.01% $3,955,986 44 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 898,456 -50,177 < 0.01% $1,814,881 3 qtrs
Summit Financial LLC Reduced 889,069 -20,361 0.02% $1,795,918 6 qtrs
The Goldman Sachs Group Inc Reduced 889,066 -1,568 < 0.01% $1,795,914 27 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
361,530
Shared
0
None
52,621

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.